Bladder sensory desensitization decreases urinary urgency
Open Access
- 11 June 2007
- journal article
- research article
- Published by Springer Nature in BMC Urology
- Vol. 7 (1) , 9
Abstract
Background: Bladder desensitization has been investigated as an alternative treatment for refractory detrusor overactivity. Most open and controlled clinical trials conducted with intravesical RTX showed that desensitization delays the appearance of involuntary detrusor contractions during bladder filling and decreases the number of episodes of urgency incontinence. Urgency is being recognised as the fundamental symptom of overactive bladder (OAB), a symptomatic complex which recent epidemiological studies have shown to affect more than 10% of the Western population. As anti-muscarinic drugs, the first line treatment for OAB, are far from being able to fully control urgency, the opportunity to test other therapeutic approaches is created. The present work was, therefore, designed as an exploratory investigation to evaluate the effect of bladder desensitization on urinary urgency. Methods: Twenty-three OAB patients with refractory urgency entered, after given informed consent, a 30 days run-in period in which medications influencing the bladder function were interrupted. At the end of this period patients filled a seven-day voiding chart where they scored, using a 0–4 scale, the bladder sensations felt before each voiding. Then, patients were instilled with 100 ml of 10% ethanol in saline (vehicle solution) and 30 days later a second seven-day voiding chart was collected. Finally, patients were instilled with 100 ml of 50 nM RTX in 10% ethanol in saline. At 1 and 3 months additional voiding charts were collected. At the end of the vehicle and 3 months period patients were asked to give their subjective impression about the outcome of the treatment and about the willingness to repeat the previous instillation. Results: At the end of the run-in period the mean number of episodes of urgency per week was 71 ± 12 (mean ± SEM). After vehicle instillation, the mean number of episodes of urgency was 56 ± 11, but only 4 patients (17%) considered that their urinary condition had improved enough to repeat the treatment. At 1 and 3 months after RTX the number of episodes of urgency decreased to 39 ± 9 (p = 0.002) and 37 ± 6 (p = 0.02), respectively (p indicates statistical differences against vehicle). The percentage of patients with subjective improvement after RTX and willing to repeat the instillation at a later occasion was 69%. Conclusion: In OAB patients with refractory urgency bladder desensitization should be further investigated as an alternative to the standard management. Additionally, the specific effect of RTX on TRPV1 receptors suggests that urothelium and sub-urothelial C-fibers play an important role to the generation of urgency sensation.Keywords
This publication has 38 references indexed in Scilit:
- The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladderNeurourology and Urodynamics, 2007
- Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract Symptoms, Urodynamic Parameters, and Quality of Life of Patients with Urodynamic Increased Bladder SensationEuropean Urology, 2006
- Therapeutic Effect of Multiple Resiniferatoxin Intravesical Instillations in Patients With Refractory Detrusor Overactivity: A Randomized, Double-Blind, Placebo Controlled StudyJournal of Urology, 2006
- Urodynamic Effect of Intravesical Resiniferatoxin in Patients with Neurogenic Detrusor Overactivity of Spinal Origin: Results of a Double-Blind Randomized Placebo-Controlled TrialEuropean Urology, 2005
- USING THE CIRCUMSTANCES OF SYMPTOM EXPERIENCE TO ASSESS THE SEVERITY OF URGENCY IN THE OVERACTIVE BLADDERJournal of Urology, 2005
- P2X3-Immunoreactive Nerve Fibres in Neurogenic Detrusor Overactivity and the Effect of Intravesical Resiniferatoxin*1European Urology, 2004
- Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan‐neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatmentBJU International, 2004
- Current and Future Pharmacological Treatment for Overactive BladderJournal of Urology, 2002
- Topography of the Vanilloid Receptor in the Human Bladder: More Than Just the Nerve FibersJournal of Urology, 2002
- Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1Nature Neuroscience, 2002